Attached files

file filename
EX-32.2 - AIM ImmunoTech Inc.ex32-2.htm
EX-32.1 - AIM ImmunoTech Inc.ex32-1.htm
EX-31.2 - AIM ImmunoTech Inc.ex31-2.htm
EX-31.1 - AIM ImmunoTech Inc.ex31-1.htm
EX-23.2 - AIM ImmunoTech Inc.ex23-2.htm
EX-21 - AIM ImmunoTech Inc.ex21.htm
EX-10.81 - AIM ImmunoTech Inc.ex10-81.htm
EX-10.80 - AIM ImmunoTech Inc.ex10-80.htm
EX-10.79 - AIM ImmunoTech Inc.ex10-79.htm
EX-10.78 - AIM ImmunoTech Inc.ex10-78.htm
EX-10.77 - AIM ImmunoTech Inc.ex10-77.htm
EX-10.76 - AIM ImmunoTech Inc.ex10-76.htm
EX-10.75 - AIM ImmunoTech Inc.ex10-75.htm
EX-4.23 - AIM ImmunoTech Inc.ex4-23.htm
10-K - AIM ImmunoTech Inc.form10-k.htm

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

AIM ImmunoTech Inc.

Ocala, Florida

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-118903, 333-155528, 333-160499, 333-209060, 333-220296, 333-227543 and 333-240315), Form S-3 (No. 333-205228 and 333-226059) and Form S-1 (No. 333-217671, 333-220756, 333-226057, 333-229051 and 333-233657) of AIM ImmunoTech Inc. of our report dated March 30, 2021, relating to the consolidated financial statements, which appears in this Form 10-K.

 

/s/ BDO USA, LLP

 

Miami, Florida

March 30, 2021